Newsroom | 4478 results

ATLANTA--(BUSINESS WIRE)--Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec and Dosimetry Services will be introduced alongside innovations from the broader Mirion portfolio, including...

CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visu...

NEW YORK--(BUSINESS WIRE)--FDA APPROVES SMILE Dx....

SAN CARLOS, California--(BUSINESS WIRE)--ZAP Surgical Systems, Inc. líder mundial en cirugía cerebral robótica no invasiva, anunció hoy los primeros tratamientos de pacientes utilizando su plataforma ZAP-X® Gyroscopic Radiosurgery® en Latinoamérica. Ubicada en Neuland, Boquerón, Paraguay, Radioterapia Concordia (www.saludconcordia.com) ha comenzado oficialmente su uso clínico, marcando un hito importante en la descentralización de la atención vanguardista para tumores cerebrales en toda la regi...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the first patient treatments using its ZAP-X® Gyroscopic Radiosurgery® platform in Latin America. Located in Neuland, Boquerón, Paraguay, Radioterapia Concordia (www.saludconcordia.com) has officially commenced clinical use, marking a major milestone in the decentralization of state-of-the-art brain tumor care across the region. In its first day of operation, f...

VIENNA, Va.--(BUSINESS WIRE)--FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine....

SANTA CLARA, Calif.--(BUSINESS WIRE)--Exo (pronounced “echo”), the leader in AI-powered, accessible medical imaging, is transforming lung disease diagnosis with another first. Now included on Exo Iris® is the first ever FDA 510(k) cleared AI for detecting pleural effusion and consolidation/atelectasis. These on-device real-time indicators empower clinicians with objective data to help detect lung diseases like pneumonia and tuberculosis at the bedside in seconds. Arun Nagdev, MD, Vice President...

BORDEAUX, France--(BUSINESS WIRE)--DESKi, a healthtech company developing AI-powered diagnostic tools in collaboration with clinicians and researchers, today announced the close of a $6 million seed round to support the U.S. and global market launch of its FDA-approved cardiac imaging software, HeartFocus. The seed round was led by Racine², an impact-focused fund managed by Serena and Makesense, with participation from BNP Paribas Développement, Épopée Gestion, Good Only Ventures, Better Angle,...

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Dr. Mikin V. Patel and Dr. Osman Ahmed have co-founded the Joint & Vascular Institute. Both doctors specialize in performing minimally invasive imaging-guided procedures to treat a multitude of diseases and health conditions, many of which once required open surgery. Dr. Patel completed his diagnostic radiology residency at the University of Chicago Medical Center and a fellowship in Vascular and Interventional Radiology at Northwestern McGaw Medical Cen...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic resonance imaging of the CNS and other body regions in adults and pediatric patients including term neonates. The submitted dose is 0.04 mmol gadolinium per kilogram body weight. If approved, gadoquatrane would become the lowest dose macrocyclic GBCA available in the U...